Summary Thymus cancer epidemiology has been little investigated, but recent clinical studies have suggested an association with the Epstein-Barr virus. We studied thymus cancer incidence 1963-83 and mortalitiy 1959-86 in England and Wales, using data from the National Cancer Register and national mortality files. Mean age-standardised incidence rates of the tumour were 0.72 per million per annum for males and 0.64 for females; mortality rates were about half of this: 0.43 for males and 0.29 for females. There was no significant change in rates over time, nor any consistent pattern of risk by region of residence. Birth cohort analysis of mortality showed in each sex, lowest risk for persons born during the Second World War. The age distribution of the tumour was unusual: a progressive rise in both incidence and mortality rates occurred in each sex at ages up to 60-69, at which there was a striking peak, more marked for males and for incidence data, with a sharp decline thereafter. Immigrants from China and Cyprus had significantly high proportional registration ratios, but based on small numbers.
The thymus gland plays an important role in the maturation of immunocompetent T-lymphocyte cells at younger ages. It enlarges until late puberty and then begins a progressive morphological and functional involution (Roitt et al., 1985) . Thymus neoplasms are rare, but since the observation in 1901 that they were associated with myasthenia gravis (Weigart, 1901) , there has been interest in their study. Their aetiology remains obscure, however, and their epidemiology is unclear because no population-based study has been carried out (Large et al., 1986) ; most of the available information comes from case-reports or relatively small hospital series (Wilkins et al., 1966; Bernatz et al., 1973; Salyer & Eggleston, 1976; Maggi et al., 1986) . Recently, some clinical studies have suggested that thymus carcinoma may be associated with Epstein-Barr virus (EBV) (Leyvraz et al., 1985; Dimery et al., 1988) .
The England and Wales national cancer registry holds an exceptionally large data set from a catchment population of about 50 million, which gave an opportunity to investigate the descriptive epidemiology of these rare tumours and potentially to give clues for the development of specific aetiological hypotheses. (Swerdlow, 1986) .
Materials and methods

Sources of data
Site of primary malignancy has been coded in the OPCS files according to the Seventh Revision of the 'International Classification of Diseases' (ICD), (World Health Organization, 1957 ) for 1959 -1967 (General Register Office, 1959 -1970 ; Office of Population Censuses and Surveys, 1971-1986 ).
Methods of analysis Directly age-standardised incidence and mortality rates were calculated using England and Wales mid-year populations as denominators and the 'World Standard' population as the standard (Smith, 1987) . To reduce random variation when examining secular trends, time series data were smoothed by a moving average of span 5 and weights 1,4,6,4,1/16 (Box & Jenkins, 1970) . The figure derived from this smoothing necessarily does not contain separate data points for the two first and two last years.
Models based on the assumption that the observed number of cancer occurrences or cancer deaths arose from a Poisson distribution were fitted to test the statistical significance of linear trends in incidence and mortality (Breslow & Day, 1987) , using the GLIM (Generalised Linear Interactive Modelling) (Baker & Nelder, 1978) computer package.
Birth cohort analyses was conducted for mortality but not for incidence, for which insufficient data were available for satisfactory analysis. Standardised cohort mortality ratios (SCMRs) were calculated for each 5-year birth cohort (Case, 1956; Beral, 1974) using, in each sex, the average age-specific mortality of England and Wales 1960-84 as the standard.
The significance of SCMRs was tested using the significance factors for the ratio of a Poisson variable to its expectation given by Bailar and Ederer (1964) .
Geographical variation in thymus cancer incidence was examined by calculating age-standardised registration rates for hospital regions of residence for 1974-83. This period was chosen because regional boundaries were changed in 1974. Region of residence was known for all registrations in the file.
72% of thymus cancer registration and, of these, 96% were born in the United Kingdom.
The significance of regional rates compared to England and Wales rates, and of proportional registration ratios by country of birth, were tested using the tables of Bailar and Ederer (1964 A total of 547 deaths with the underlying cause thymus cancer occurred during 1959-86, of which 51.6% (282) were males and 48.4% (265) were females.
Age-standardised incidence (registration) rates are shown in Figure 1 . There was no significant linear trend (males: observed slope b = -0.007, P>0.10; females: b = -0.013, P>0.10) nor was there any correlation between male and female rates in the same years (r = 0.05, P = 0.83).
Similarly, annual age-standardised death rates (Figure 1) showed no evidence of a trend over time (males: b = -0.0005, P>0.10; females: b = 0.011; P>0.10), and also no correlation between male and female death rates for the same years (r = 0.13, P = 0.52). On examination of mortality by birth cohort (Figure 2) , there was no consistent trend, but in each sex, persons born during the Second World War had the lowest risk, although only significantly below 100 for males (males: SCMR = 15, P<0.05; females: SCMR = 59, P>0.05). Both values were based on small numbers of deaths (males = 2; females = 6).
Examining the age distribution of thymus cancer using aggregated data for the entire study period (Figure 3) , both incidence and mortality in each sex showed a steady increase in rates up to a peak at ages 60-69, and thereafter a striking decline in rates, particularly in males and for incidence. The overall male excess of thymus cancer incidence was accounted for by the male predominance at the older ages at which the peak occurred, whereas there was no clear sex difference at younger age-groups. Table II shows the geographical distribution of thymus cancer in England and Wales for 1974-83. Males rates were higher than female rates for all regions except Wessex and Oxford; highest rates in males were in East Anglia followed by the Northern and North East Thames regions. Females rates were highest in Wessex (the region with the lowest male rate), followed by Oxford and East Anglia. There was no correlation between male and female rates for the same regions (r = 0.25; P = 0.363).
Analysis by country by birth showed significant PRRs for migrants born in China (PRR = 1,852; P<0.05) and Cyprus (PRR = 744; P<0.05), but based on very small numbers of registrations (China = 2; Cyprus = 3). (Rosai, 1985) , since the vast majority are morphologically indistinguishable from benign thymomas (Chen, 1984) . The distinction between slight invasion and no invasion is not always clear, however (Jain & Frable, 1974) . Despite these uncertainties, the similarity of the results for incidence with those for mortality in the present study give some indication that such diagnostic effects are unlikely to have affected the quality of the incidence data greatly. Second, even to establish that a tumour has originated from the thymus parenchyma is not always an easy task. For instance the nature of 'granulomatous thymomas' and 'seminomatous thymomas', and their relation to Hodgkin's disease (Keller & Castleman, 1974) and germ cell tumours (Levine, 1973) (Smith, 1987) .
bDiffers significantly from England and Wales at P<0.05.
Two additional issues of coding should also be noted. First, thymomas might fail to be coded as thymus cancer if the word malignant was arbitrarily omitted on the medical record. Second, the thymus cancer data exclude thymic lymphomas which are allocated in the ICD to lymphoma rather than thymus cancer. The impact of the first is difficult to assess. The effect of the second would have been small since lymphomas arising primarily within the thymus gland are rare (Keller & Castleman, 1974) .
That mortality rates were substantially lower than the corresponding incidence rates agree with clinical studies which report a relatively good survival for malignant thymomas, which form the great majority of thymus cancers (Batata et al., 1974; Verley & Hollman, 1985; Maggi et al., 1986) . Since classification might be ambiguous, no attempt was made to analyse the data further by histological category.
Some clinical reports have suggested an increasing frequency of diagnosis of thymomas in the past decade (Maggi et al., 1986) , but considered that this was probably due to changes in diagnostic and therapeutic approaches for myasthenia gravis rather then a true increase in incidence. Our population-based study did not show an increase in incidence. Since diagnostic or therapeutic policy changes in the recent period may have led to the detection of small thymomas which would not have been detected in other ways, and cancer registration has probably improved over time (Swerdlow, 1986) , our data might hide a possible decrease in incidence over time but are unlikely to correspond to an increase. The lack of correlation between male and female rates over the regions of England and Wales suggests that our incidence data have not been grossly affected by regional incompleteness, which would presumably have affected both sexes similarly. A lack of secular increase also corresponds with data from clinical series from Papworth Hospital, Cambridge (Large et al., 1986) .
The age distribution of thymus cancer is unusual. Lymphoreticular cancers (Greene, 1982) , nasopharyngeal cancer (NPC) (Shanmugaratnam, 1982) and certain other tumours arising in immunodeficient conditions for which a viral aetiology has been suspected (Kinlen, 1982) , share with thymus cancer a peak in late middle age, but show some differences in age distribution, notably in the degree of decrease at older ages. The distribution of thymus cancer is particularly similar to that of NPC in high incidence populations, e.g. Singapore (Shanmugaratnam, 1982) , and also of Creutzfeldt-Jakob disease (P.G. Smith, personal communication), a neurological disorder suspected of being caused by a slow viral agent (Roos et al., 1973) . In the cancers above, rates start to rise earlier and steeper than in most malignancies, which may suggest that exposure to carcinogenic agents begins very early in life. The extraordinary decline of thymus cancer after late middle age might perhaps indicate cessation of exposure to an aetiological agent or a decreasing number of susceptibles in the population, although in part it might be due to the decline at older ages in thymectomies for myasthenia and, hence, less probability of detecting clinically silent thymomas. Rates start to go down when the thymus gland is already morphologically involuted but still preserves some functional activity (Roitt et al., 1985) .
The similarities with NPC are particularly interesting because the nasopharynx and thymus have the same embryological origin from the primitive foregut (Leyvraz et al., 1985) , and because a serological association with EBV has been well documented for NPC (Shanmugaratnam, 1982) and has recently been reported for thymus cancer (Leyvraz et al., 1985; Dimery et al., 1988) . Like thymus cancer, NPC also shows stable time trends (Shanmugaratnam, 1982) . The most outstanding epidemiological feature of NPC, however, is its very high incidence in southern Chinese, both in and outside China (Shanmugaratnam, 1982) . High rates are found in other groups in South East Asia, especially Filipinos, and in Tunisians (Hirayama, 1978) . Although our data showed a significant high risk of thymus cancer among persons born in China and in Cyprus, no coherent pattern was present. Thymus cancer data have only been published in Cancer Incidence in Five Continents in the latest edition, and very small numbers make interpretation difficult: apart from a very high incidence (1.7 per 100,000 per annum) in Filipino males in Bay Area, United States, no clear geographical or ethnic differentials were present.
The low SCMRs observed in both sexes for the generation born during the Second World War might also relate to a putative viral aetiology, since a small average family size characterised that time (Beral et al., 1978) and, hence, perhaps there was a lesser probability of acquiring infectious diseases (Reves, 1985) . The method used to calculate the cohort ratios tend to underestimate real decreases, because of the overlap of adjacent generations (Beral, 1974) and because of the inevitable use of the overall data to generate the expected values. It should be noted also that the ratios were based on small numbers. Since these are recent birth cohorts, their follow-up as they age will help to clarify this issue.
The role of EBV in human cancers is still controversial even for NPC, a tumour with which the virus has been strongly associated (Henderson, 1989) . That thymic cells may contain EBV genome has been postulated in reports of EBVinduced malignant lymphoproliferative disorders arising in patients subject to thymic transplantation (Reece et al., 1981) , but the relation, if any, with thymus cancer is unclear.
So far, EBV has only been shown to be associated with lymphoepitheliomas (Leyvraz et al., 1985; Dimery et al., 1985) , a small sub-group of thymus carcinoma (Chen, 1984) , and it is not known if there is a link for other morphological types of thymus cancer.
Further epidemiological investigation of the parallels between NPC and thymus cancer may be worthwhile to pursue.
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